APA (7th ed.) Citation

L, G., CJ, P., G, G., C, F., Q, F., & MJ, C. (2025). Ivabradine in treatment of symptomatic heart failure and supraventricular tachycardias in patients under six months of age. Frontiers in pharmacology, 16, 1502375. https://doi.org/10.3389/fphar.2025.1502375

Chicago Style (17th ed.) Citation

L, Gómez-Ganda, Parramón-Teixidó CJ, Giralt-García G, Fernández-García C, Ferrer-Menduiña Q, and Cabañas-Poy MJ. "Ivabradine in Treatment of Symptomatic Heart Failure and Supraventricular Tachycardias in Patients Under Six Months of Age." Frontiers in Pharmacology 16 (2025): 1502375. https://doi.org/10.3389/fphar.2025.1502375.

MLA (9th ed.) Citation

L, Gómez-Ganda, et al. "Ivabradine in Treatment of Symptomatic Heart Failure and Supraventricular Tachycardias in Patients Under Six Months of Age." Frontiers in Pharmacology, vol. 16, 2025, p. 1502375, https://doi.org/10.3389/fphar.2025.1502375.